Cosopt and Promethazine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cosopt (dorzolamide hydrochloride; timolol maleate) and Promethazine (promethazine hydrochloride). Common drug interactions include asthenia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Cosopt and Promethazine. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Cosopt?
Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 9,029 Cosopt users. Check the latest studies of Cosopt.
What is Promethazine?
Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.
18 people who take Cosopt and Promethazine together, and have interactions are studied.

What are the common drug interactions of Cosopt and Promethazine, by gender? *:
female:
- Asthenia (weakness)
- Atrophic vulvovaginitis (inflammation of the vulva)
- Back disorder
- Benign neoplasm of adrenal gland (benign (non-cancerous) tumours of the adrenal gland)
- Blindness
- Bone disorder
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Bruxism (habitual grinding of the teeth, typically during sleep)
- Cataract (clouding of the lens inside the eye)
- Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
male:
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Renal injury (kidney injury)
- Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)
- Tooth injury
- Tooth loss
- Weight decreased
- Bone pain
- Dental caries
- Depressed mood
What are the common drug interactions of Cosopt and Promethazine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Chronic kidney disease
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal tubular necrosis (death of kidney tubules)
30-39:
n/a
40-49:
n/a
50-59:
- Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Chronic kidney disease
- Confusional state
- Constipation
- Cough
- Death
- Decreased interest
- Delusion (a false belief or opinion)
- Depression
60+:
- Fall
- Neuropathy peripheral (surface nerve damage)
- Cellulitis (infection under the skin)
- Compression fracture (fracture due to pressure caused by injury)
- Constipation
- Cough
- Device failure
- Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
- Dyspnoea (difficult or laboured respiration)
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 27.78%
- High Blood Pressure: 5 people, 27.78%
- Pain: 5 people, 27.78%
- Diabetes: 3 people, 16.67%
- High Blood Cholesterol: 3 people, 16.67%
- Depression: 3 people, 16.67%
- Hypersensitivity: 2 people, 11.11%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 11.11%
- Herpes Virus Infection: 2 people, 11.11%
- Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Cosopt and Promethazine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cosopt (9,029 reports)
- Promethazine (32,300 reports)
Browse all drug interactions of Cosopt and Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cosopt:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Promethazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cosopt and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Promethazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on dorzolamide hydrochloride; timolol maleate and promethazine hydrochloride (the active ingredients of Cosopt and Promethazine, respectively), and Cosopt and Promethazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Keflex cause Purpura? - 13 seconds ago
- Could Synthroid cause Burkitt Lymphoma? - 17 seconds ago
- Could Coumadin cause Eye Discharge? - 22 seconds ago
- Could Acetaminophen cause Panic Disorder? - 22 seconds ago
- Could Coumadin cause Infusion Site Erythema? - 22 seconds ago
- Could Ketek cause Weakness? - 23 seconds ago
- Schizoaffective Disorder and Sedation - 28 seconds ago
- Drug interactions of B12 and Ganciclovir - 34 seconds ago
- Could Keppra cause Consciousness - Decreased? - 34 seconds ago
- Drug interactions of Coreg and Sublimaze - 39 seconds ago